MX342946B - Derivados de trisacaridos, y su uso como adyuvantes. - Google Patents
Derivados de trisacaridos, y su uso como adyuvantes.Info
- Publication number
- MX342946B MX342946B MX2012014422A MX2012014422A MX342946B MX 342946 B MX342946 B MX 342946B MX 2012014422 A MX2012014422 A MX 2012014422A MX 2012014422 A MX2012014422 A MX 2012014422A MX 342946 B MX342946 B MX 342946B
- Authority
- MX
- Mexico
- Prior art keywords
- trisaccharide
- adjuvants
- derivatives
- trisaccharides
- adjuvant compositions
- Prior art date
Links
- 150000004043 trisaccharides Chemical class 0.000 title abstract 8
- 239000002671 adjuvant Substances 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 abstract 2
- 125000000129 anionic group Chemical group 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 125000005313 fatty acid group Chemical group 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10165707A EP2397484A1 (en) | 2010-06-11 | 2010-06-11 | Trisaccharide derivates, and their use as adjuvants |
| PCT/NL2011/050393 WO2011155822A1 (en) | 2010-06-11 | 2011-06-03 | Trisaccharide derivates, and their use as adjuvants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2012014422A MX2012014422A (es) | 2013-08-27 |
| MX342946B true MX342946B (es) | 2016-10-18 |
Family
ID=43734127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012014422A MX342946B (es) | 2010-06-11 | 2011-06-03 | Derivados de trisacaridos, y su uso como adyuvantes. |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US9327020B2 (https=) |
| EP (3) | EP2397484A1 (https=) |
| JP (2) | JP6004586B2 (https=) |
| KR (1) | KR101929973B1 (https=) |
| CN (1) | CN103154013B (https=) |
| AU (1) | AU2011262606B2 (https=) |
| BR (1) | BR112012031440A2 (https=) |
| CA (1) | CA2802023C (https=) |
| CY (1) | CY1119704T1 (https=) |
| DK (1) | DK2580226T3 (https=) |
| ES (1) | ES2654156T3 (https=) |
| HR (1) | HRP20171947T1 (https=) |
| HU (1) | HUE035187T2 (https=) |
| IL (1) | IL223570A (https=) |
| LT (1) | LT2580226T (https=) |
| MX (1) | MX342946B (https=) |
| NO (1) | NO2580226T3 (https=) |
| PL (1) | PL2580226T3 (https=) |
| PT (1) | PT2580226T (https=) |
| RS (1) | RS56690B1 (https=) |
| RU (1) | RU2595717C2 (https=) |
| SI (1) | SI2580226T1 (https=) |
| SM (1) | SMT201700603T1 (https=) |
| WO (1) | WO2011155822A1 (https=) |
| ZA (1) | ZA201209395B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2397484A1 (en) * | 2010-06-11 | 2011-12-21 | Immunovo B.V. | Trisaccharide derivates, and their use as adjuvants |
| PL3193923T3 (pl) | 2014-07-24 | 2020-03-31 | Litevax B.V. | Adiuwanty |
| KR102922337B1 (ko) | 2023-10-11 | 2026-02-05 | 세종대학교산학협력단 | 삼당류의 제조방법 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4232150A (en) * | 1979-07-09 | 1980-11-04 | American Cyanamid Company | Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses |
| GB8703128D0 (en) * | 1987-02-11 | 1987-03-18 | Donmarn Ltd | Anti-scaling compounds |
| US5543505A (en) * | 1993-03-15 | 1996-08-06 | Sloan-Kettering Institute For Cancer Research | Synthetic compounds which bind to H. pylori, and uses thereof |
| US6303120B1 (en) * | 1994-03-15 | 2001-10-16 | Memorial Sloan-Kettering Institute For Cancer Research | Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| US5708163A (en) * | 1994-03-15 | 1998-01-13 | Sloan-Kettering Institute Of Cancer Research | Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof |
| ES2208687T3 (es) * | 1994-08-04 | 2004-06-16 | Elan Drug Delivery Limited | Sistema de administracion de sustancias solidas para la liberacion controlada de moleculas incorporadas en tales sustancias y procedimientos para la fabricacion de tales sistemas. |
| BE1008978A5 (fr) | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
| US6517860B1 (en) * | 1996-12-31 | 2003-02-11 | Quadrant Holdings Cambridge, Ltd. | Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery |
| US6352722B1 (en) * | 1997-12-23 | 2002-03-05 | Quadrant Holdings Cambridge Limited | Derivatized carbohydrates, compositions comprised thereof and methods of use thereof |
| JP3041799B1 (ja) * | 1998-09-29 | 2000-05-15 | 株式会社微生物化学研究所 | 新規なアジュバント及びそれを用いたワクチン |
| EP1104767A1 (en) * | 1999-11-30 | 2001-06-06 | Stichting Dienst Landbouwkundig Onderzoek | Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups |
| GB0124710D0 (en) * | 2001-10-15 | 2001-12-05 | Quadrant Healthcare Uk Ltd | Therapeutic composition |
| DE602005010101D1 (de) * | 2005-12-01 | 2008-11-13 | Wella Ag | Verwendung von Di- oder Oligosaccharidepolyestern in Haarstylingprodukten |
| US9045516B2 (en) * | 2007-04-16 | 2015-06-02 | Suri Saranathan Iyer | Synthetic ligands for the differentiation of closely related toxins and pathogens |
| WO2009140683A1 (en) * | 2008-05-16 | 2009-11-19 | Research Foundation Of The City University Of New York | Living copolymer protein/peptide hybrids for biomedical applications |
| CA2750188C (en) * | 2009-02-02 | 2016-11-29 | Otsuka Chemical Co., Ltd. | Low-molecular polysulfated hyaluronic acid derivative and compositions containing same |
| EP2397484A1 (en) * | 2010-06-11 | 2011-12-21 | Immunovo B.V. | Trisaccharide derivates, and their use as adjuvants |
-
2010
- 2010-06-11 EP EP10165707A patent/EP2397484A1/en not_active Withdrawn
-
2011
- 2011-06-03 KR KR1020137000623A patent/KR101929973B1/ko not_active Expired - Fee Related
- 2011-06-03 BR BR112012031440A patent/BR112012031440A2/pt not_active Application Discontinuation
- 2011-06-03 AU AU2011262606A patent/AU2011262606B2/en not_active Ceased
- 2011-06-03 DK DK11725217.1T patent/DK2580226T3/en active
- 2011-06-03 SI SI201131368T patent/SI2580226T1/en unknown
- 2011-06-03 CA CA2802023A patent/CA2802023C/en not_active Expired - Fee Related
- 2011-06-03 RS RS20171307A patent/RS56690B1/sr unknown
- 2011-06-03 JP JP2013514126A patent/JP6004586B2/ja not_active Expired - Fee Related
- 2011-06-03 MX MX2012014422A patent/MX342946B/es active IP Right Grant
- 2011-06-03 NO NO11725217A patent/NO2580226T3/no unknown
- 2011-06-03 PL PL11725217T patent/PL2580226T3/pl unknown
- 2011-06-03 EP EP11725217.1A patent/EP2580226B1/en active Active
- 2011-06-03 RU RU2013100945/04A patent/RU2595717C2/ru active
- 2011-06-03 WO PCT/NL2011/050393 patent/WO2011155822A1/en not_active Ceased
- 2011-06-03 HR HRP20171947TT patent/HRP20171947T1/hr unknown
- 2011-06-03 CN CN201180034937.5A patent/CN103154013B/zh not_active Expired - Fee Related
- 2011-06-03 LT LTEP11725217.1T patent/LT2580226T/lt unknown
- 2011-06-03 EP EP17204140.2A patent/EP3312188A1/en not_active Withdrawn
- 2011-06-03 SM SM20170603T patent/SMT201700603T1/it unknown
- 2011-06-03 PT PT117252171T patent/PT2580226T/pt unknown
- 2011-06-03 US US13/703,329 patent/US9327020B2/en not_active Expired - Fee Related
- 2011-06-03 HU HUE11725217A patent/HUE035187T2/hu unknown
- 2011-06-03 ES ES11725217.1T patent/ES2654156T3/es active Active
-
2012
- 2012-12-11 ZA ZA2012/09395A patent/ZA201209395B/en unknown
- 2012-12-11 IL IL223570A patent/IL223570A/en active IP Right Grant
-
2016
- 2016-04-05 US US15/090,853 patent/US20170057987A1/en not_active Abandoned
- 2016-06-15 JP JP2016119032A patent/JP2016216471A/ja active Pending
-
2017
- 2017-12-21 CY CY20171101340T patent/CY1119704T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU24272B1 (es) | Derivados de tetrahidropirido-pirimidina como inhibidores de mek | |
| NI201400005A (es) | Indazoles | |
| MX338078B (es) | Cristales de anticuerpos anti-esclerostina y formulaciones de los mismos. | |
| MX352324B (es) | Vacunas multivalentes de nanovehiculos sinteticos. | |
| MX385408B (es) | Microorganismos que producen ácido eicosapentaenoico, composiciones de ácidos grasos, y métodos para prepararlos y usos de los mismos. | |
| ECSP14004812A (es) | Triazolopiridinas sustituidas | |
| BR112013022397A2 (pt) | vacinas combinadas com doses menores de antígeno e/ou adjuvante | |
| CR20140237A (es) | Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
| BR112012017831A8 (pt) | micro-organismos produtores de ácido eicosapentaenoico, composições de ácido graxo e métodos de fabricação e uso dos mesmos | |
| CR20130676A (es) | Composiciones de lipidos algales y metodos para prepararlas y utilizarlas | |
| BR112014018032A2 (pt) | método para produzir uma composição | |
| MX347573B (es) | Composiciones y metodos para incrementar la estabilidad de aditivos para productos alimenticios. | |
| ECSP12012031A (es) | Composición farmacéutica que comprende oligopéptidos | |
| BR112017022209A2 (pt) | composição aquosa que compreende éster de ácido omega- aminocarboxílico e álcool graxo e seu uso | |
| UY35046A (es) | Cepa muscodor albus que produce compuestos orgánicos volátiles y métodos de uso | |
| MX362752B (es) | Formas mórficas de ésteres de hexadeciloxipropil-fosfonato. | |
| AR087254A1 (es) | Gliceratos de metales alcalinos y alcalinoterreos para la desacidificacion y secado de esteres de acidos grasos | |
| CL2017001588A1 (es) | Ácidos piridil-cicloalquil-carboxílicos sustituidos, composiciones que los contienen y usos de los mismos | |
| IN2014MN01671A (https=) | ||
| CR20120592A (es) | Intermedios de agomelatina y métodos de preparación de estos | |
| GB201412395D0 (en) | Fatty acid ester compositions for use as emollients | |
| MX342946B (es) | Derivados de trisacaridos, y su uso como adyuvantes. | |
| CR20110251A (es) | Metodo para la obtencion de un extracto rico en taninos del acido elágico a partir de frutos que contiednen estos compuestos y extracto obtenido usando dicho metodo. | |
| BR112014013906A8 (pt) | ésteres de fosfato aromáticos como componentes de formulação agroquímica | |
| IN2015DN00085A (https=) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |